Dr. Wen Xia 夏雯
Chief Physician
Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Personalized treatment and full-course management of breast cancer, including benign and malignant tumors. Expertise in screening, genetic counseling, chemotherapy, endocrine therapy, targeted therapy, and clinical trials of new anti-cancer drugs.
Dr. Xia holds a PhD from Peking Union Medical College (Tsinghua University School of Medicine). Currently with the Breast Cancer Group at Sun Yat-sen University Cancer Center. Completed exchanges at University Hospitals Cleveland Medical Center (Case Western Reserve University) and Hôpital Pitié-Salpêtrière in Paris. Serves as a sub-investigator in multiple international and domestic multicenter clinical trials.
Professional roles
- Member, Young Committee of the Breast Cancer Professional Committee, Chinese Research Hospital Association
- Member, Breast Cancer Professional Committee, Guangdong Chest Tumor Prevention and Treatment Research Association
Name order: in Chinese the family name comes first (Xia Wen). Papers usually list the name as Wen Xia or Xia W.
Selected publications
68 papers on PubMed matched by name and affiliation; 3 as first or senior author since 2016. Most recent first- or senior-author papers:
- Breast Cancer Res, 2025 (senior author): Trastuzumab deruxtecan in patients with active brain metastases from HER2-positive/low metastatic breast cancer: a retrospective multicenter real-world study. PubMed 40691796
- BMC Cancer, 2024 (senior author): Prognostic significance of the novel immunonutritional marker of cholesterol-to-lymphocyte ratio in patients with non-metastatic breast cancer. PubMed 39080568
- Drug Des Devel Ther, 2021 (senior author): Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus. PubMed 34408400
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion